Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data

Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data

Wave Life Sciences Ltd. (NASDAQ: WVE) is back in the spotlight on December 18, 2025—not because of a brand-new press release, but because the stock is still digesting one of the most volatile biotech weeks of the year. In Thursday trading, WVE stock fell roughly mid-single digits, hovering in the mid-$15 range after closing around $16.34 the prior session, according to market data and widely circulated market recaps. StockAnalysis+1 That pullback matters because it comes right after a dramatic early-December surge tied to Wave’s obesity program—and immediately following a large equity financing that materially changes the company’s cash position and
18 December 2025
Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stock slid sharply on Thursday, December 18, 2025, after a regulatory filing revealed a leadership transition involving the company’s Chief Medical and Development Officer. In trading, CRNX fell roughly 8% to around the mid‑$40s, with the day’s range stretching from the low‑$40s to the high‑$40s as investors digested the update. Investing.com For a biotech stock—especially one in the middle of a major product launch and multiple late‑stage trials—management continuity matters. But so do fundamentals: Crinetics is no longer “just” a clinical-stage story. It recently reached a pivotal milestone with its first FDA-approved product, and its
18 December 2025
·
Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Dec. 18, 2025 — Birkenstock Holding plc (NYSE: BIRK) delivered a classic “beat-and-drop” session: strong fiscal 2025 results and record revenue were overshadowed by a more cautious fiscal 2026 outlook that bakes in tariff and currency pressure. SEC+1 As of the latest available trade on Dec. 18, Birkenstock shares were at $42.58, down about 8% on the day, after swinging between $39.73 and $46.75 in heavy volume. The market’s message was blunt: investors liked what Birkenstock just did, but they’re repricing what it may earn next—especially if tariffs and foreign-exchange (FX) headwinds prove sticky. What’s happening with Birkenstock stock today
18 December 2025
··
Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

December 18, 2025 — Edgewise Therapeutics, Inc. (NASDAQ: EWTX) saw its shares slide sharply in Thursday trading, a reminder that clinical-stage biotech stocks can move fast even when there’s no single headline screaming for attention. EWTX finished the session around $20.35, down roughly 8.8% from the prior close, after trading between about $20.33 and $22.81. StockAnalysis That drop matters because the Edgewise story is still mostly about future clinical readouts and regulatory path clarity, not current product revenue. The company is advancing late-stage work in muscular dystrophies (with its lead program, sevasemten) and also developing cardiac sarcomere modulators for conditions
18 December 2025
··
ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries Incorporated (NYSE: ABM) stock was sharply lower in Thursday trading (December 18, 2025), with shares recently changing hands near $43.13, down about 10.6% from the prior close after a volatile session that saw the stock trade between $43.02 and $47.63. The move follows a dense burst of company updates released on December 17: ABM’s fiscal fourth-quarter and full-year 2025 results, a fiscal 2026 outlook, a dividend increase, and a major acquisition announcement—plus fresh analyst commentary today that put margins and leverage back at the center of the debate. GlobeNewswire+2ABM+2 Why ABM stock is moving today The immediate catalyst
18 December 2025
···
Inspire Medical Systems (INSP) Stock Plunges on Medicare Coding Reversal: Latest News, Analyst Forecasts, and What Investors Are Watching

Inspire Medical Systems (INSP) Stock Plunges on Medicare Coding Reversal: Latest News, Analyst Forecasts, and What Investors Are Watching

Inspire Medical Systems, Inc. (NYSE: INSP) stock tumbled sharply on Thursday, December 18, 2025, after a key Medicare coding tailwind that had fueled recent optimism suddenly looked far less certain. By early afternoon in the U.S. session, INSP was down in the mid-to-high teens, reflecting investor anxiety that a reimbursement “upgrade” tied to a specific billing code may not stick—at least not in the clean, nationwide way many had modeled. MarketBeat What happened to INSP stock on 18.12.2025? The immediate catalyst: two Medicare Administrative Contractors (MACs)—CGS and Noridian—reportedly pulled CPT code 64568 for hypoglossal nerve stimulation (HGNS) and redirected billing
18 December 2025
Insmed Stock (NASDAQ: INSM) Slides on Brensocatib Sinus-Trial Failure; Analysts Reset Forecasts

Insmed Stock (NASDAQ: INSM) Slides on Brensocatib Sinus-Trial Failure; Analysts Reset Forecasts

December 18, 2025 — Insmed Incorporated (NASDAQ: INSM) shares dropped sharply Thursday after the company disclosed a Phase 2b setback for brensocatib in a chronic sinus condition and said it is discontinuing development in that indication, even as it simultaneously added a new Phase 2–ready antibody to its pipeline. SEC+1 Insmed stock was trading around $166.75 in the afternoon snapshot available from market data, down about 16% on the day, after touching an intraday low of $158.06 and high of $173.99. What happened to INSM stock on December 18, 2025 The selloff traces back to Insmed’s disclosure that its Phase
18 December 2025
···
Upstart Stock News Today: UPST Jumps on Tech CU Partnership as Wall Street Weighs 2026 Outlook (Dec. 18, 2025)

Upstart Stock News Today: UPST Jumps on Tech CU Partnership as Wall Street Weighs 2026 Outlook (Dec. 18, 2025)

Upstart Holdings, Inc. (NASDAQ: UPST) is back in the spotlight on December 18, 2025 (18.12.2025), with the AI-lending stock pushing higher as traders react to fresh partner momentum in credit unions—and try to square that optimism with a still-volatile macro and a sharply divided analyst community. Shares were trading around the high-$40s on Thursday, up roughly 8% on the session at the time of this writing. Investing.com That move follows a choppy stretch for UPST, where single-day swings have become a feature, not a bug. Today’s catalyst is fairly clear: a new credit union partnership that reinforces Upstart’s strategy of
18 December 2025
·
ICE Barcelona 2026: Malta’s iGaming Push, Property Appeal and the EU’s Ukraine Funding Crunch

ICE Barcelona 2026: Malta’s iGaming Push, Property Appeal and the EU’s Ukraine Funding Crunch

Valletta / Brussels / Barcelona — December 18, 2025.Across Europe today, three storylines converged around the same theme: predictability—who can offer it, who needs it, and how much it costs. In Brussels, EU leaders entered what diplomats described as a make-or-break summit over a proposed €90 billion “reparations loan” for Ukraine, backed by profits from frozen Russian central bank assets—a plan that has exposed deep legal and financial anxieties inside the bloc. Reuters+2The Guardian+2 In the Mediterranean, Malta is leaning hard into the opposite narrative: a small jurisdiction selling stability at scale. On the same day, GamingMalta detailed how it
18 December 2025
BETA Technologies Stock (NYSE: BETA) Surges as BofA Raises Price Target and U.S. DOT Unveils Advanced Air Mobility Roadmap

BETA Technologies Stock (NYSE: BETA) Surges as BofA Raises Price Target and U.S. DOT Unveils Advanced Air Mobility Roadmap

BETA Technologies, Inc. stock (NYSE: BETA) became one of the more talked-about “future of flight” trades on December 18, 2025, as a classic one-two catalyst landed on the tape: a fresh analyst price-target increase from Bank of America and a major federal policy signal for the advanced air mobility (AAM) sector. By the latest reported trade late Thursday, BETA shares were at $29.88, up 6.83%, after touching an intraday high of $30.49. That price action is happening in a stock that only recently entered the public markets—BETA raised about $1.01 billion in its IPO at $34 per share, debuting on
18 December 2025
·
Karman Holdings (KRMN) Stock: News, Forecasts, and Analyst Outlook for December 18, 2025

Karman Holdings (KRMN) Stock: News, Forecasts, and Analyst Outlook for December 18, 2025

Karman Holdings Inc. (best known as Karman Space & Defense) is back on investors’ radar on Thursday, December 18, 2025, as fresh institutional ownership data and new valuation commentary collide with an already-heated 2025 run in aerospace and defense equities. One important housekeeping note up front: Karman Holdings Inc. trades on the NYSE under ticker KRMN—not ONDS. Reuters+1ONDS is the ticker for Ondas Holdings Inc., a separate defense-and-autonomy company that also made news today. Ondas Holdings Inc. With that clarified, here’s what’s new (and what matters) for Karman (KRMN) stock as of 12/18/2025, pulling together the day’s news, forecasts, and
18 December 2025
·
Applied Digital Corporation (APLD) Stock Jumps on New Macquarie Loan Facility: Today’s News, Analyst Forecasts, and What to Watch Next

Applied Digital Corporation (APLD) Stock Jumps on New Macquarie Loan Facility: Today’s News, Analyst Forecasts, and What to Watch Next

Applied Digital Corporation stock (NASDAQ: APLD) is snapping back on December 18, 2025, after a choppy week for “AI infrastructure” names. Shares were trading around $23.63 in midday U.S. trading, up roughly $1.63 (about 7.4%) from the prior close, with heavy volume as investors reacted to fresh financing news. MarketScreener That bounce matters because it arrives in the middle of a broader market argument: is the AI data-center boom still a gold rush—or are lenders and investors starting to ask harder questions about who pays for all this concrete, copper, power gear, and GPUs? Recent headlines around data-center financing (including
18 December 2025
·
Almonty Industries Stock (ALM, AII) on 18 December 2025: Sangdong Mine Hits “First Ore” Milestone, Funding Overhang Clears, and Analysts Re-Run the Models

Almonty Industries Stock (ALM, AII) on 18 December 2025: Sangdong Mine Hits “First Ore” Milestone, Funding Overhang Clears, and Analysts Re-Run the Models

Almonty Industries Inc. stock is back in the market’s spotlight on Thursday, December 18, 2025, as investors digest a rare combo of real-world progress underground and capital-markets cleanup above ground. The company says it has delivered the first truckload of ore to the run‑of‑mine (ROM) pad at its flagship Sangdong Tungsten Mine in South Korea—an operational handoff from “build mode” into “mine mode,” and a key step on the road to full-scale tungsten concentrate production. Business Wire In the U.S. listing, Almonty Industries (NASDAQ: ALM) traded around $8.52 late in the session, up roughly 8.7% versus the prior close, with
18 December 2025
···
Core Natural Resources (CNR) Stock Jumps on Leer South Restart: 2026 Outlook, Analyst Targets, and What to Watch

Core Natural Resources (CNR) Stock Jumps on Leer South Restart: 2026 Outlook, Analyst Targets, and What to Watch

Core Natural Resources, Inc. (NYSE: CNR) shares surged Thursday after the coal producer announced a major operational milestone: the restart of longwall mining at its Leer South metallurgical mine in West Virginia. The move helped push CNR stock to about $90 in late trading, up roughly 8% on the day, with the session ranging from the low $80s to low $90s. This is Core Natural Resources (the coal company)—not to be confused with other “CNR” tickers in global markets. What happened on Dec. 18: Leer South longwall mining is back online In a release dated Dec. 18, 2025, Core said
18 December 2025
·
Rocket Lab Stock Jumps After Early U.S. Space Force Launch: RKLB News, Forecasts, and Fresh 2025 Valuation Debate (Dec. 18, 2025)

Rocket Lab Stock Jumps After Early U.S. Space Force Launch: RKLB News, Forecasts, and Fresh 2025 Valuation Debate (Dec. 18, 2025)

Rocket Lab Corporation (Nasdaq: RKLB) is back in the headlines on December 18, 2025, after the company pulled off a national-security launch ahead of schedule—an operational flex that helped lift the stock in Thursday trading and reignited the ongoing tug‑of‑war between “execution momentum” and “already-priced-in optimism.” Rocket Lab stock today: what’s driving RKLB on Dec. 18, 2025 Rocket Lab said it successfully launched the STP‑S30 mission for the U.S. Space Force’s Space Systems Command, completing the mission five months ahead of schedule. The launch—named “Don’t Be Such A Square”—lifted off just after midnight from Launch Complex 2 at the Mid‑Atlantic
18 December 2025
····
Blue Origin Stands Down NS-37 Launch After Preflight Issue, Delaying Historic Flight for First Wheelchair User to Reach Space

Blue Origin Stands Down NS-37 Launch After Preflight Issue, Delaying Historic Flight for First Wheelchair User to Reach Space

Blue Origin called off its planned New Shepard NS-37 launch attempt on Thursday, Dec. 18, 2025, saying the team “observed an issue” during built-in preflight checks and is now assessing the next opportunity to launch. The suborbital mission is closely watched because it is slated to carry Michaela “Michi” Benthaus, an aerospace and mechatronics engineer who uses a wheelchair—positioning her to become the first wheelchair user to travel beyond the Kármán line, the widely recognized boundary of space. Blue Origin+1 The delayed flight is more than a space-tourism headline. It has become a high-profile test of how commercial spaceflight can
18 December 2025
Ondas Holdings (ONDS) Stock Today (Dec. 18, 2025): Shares Rally on Demining Pilot Results, New COO, and Fresh Analyst Targets

Ondas Holdings (ONDS) Stock Today (Dec. 18, 2025): Shares Rally on Demining Pilot Results, New COO, and Fresh Analyst Targets

Ondas Holdings Inc. (NASDAQ: ONDS) is back in the market’s spotlight on Thursday, December 18, 2025, with the stock trading around the $8 level and showing sharp intraday gains on unusually heavy volume—a reminder that ONDS is currently priced like a fast-moving “story stock,” not a sleepy industrial. As of the latest available real-time snapshot, ONDS was up roughly 8% on the session (to about $7.99) with tens of millions of shares traded. StockAnalysis What’s behind the move? Two company announcements dated Dec. 18—one tied to AI-driven humanitarian demining and one tied to executive leadership and scale—landed as investors are
18 December 2025
·
Banco BBVA Argentina (BBAR) Stock Surges on Dec. 18, 2025: Dividend Headlines, FX Overhaul Tailwinds, and Where Analysts See the Shares Next

Banco BBVA Argentina (BBAR) Stock Surges on Dec. 18, 2025: Dividend Headlines, FX Overhaul Tailwinds, and Where Analysts See the Shares Next

New York / Buenos Aires — December 18, 2025. Banco BBVA Argentina S.A. shares are back in the spotlight today after a sharp move higher in U.S. trading. The bank’s NYSE-listed American Depositary Shares (ADS) (ticker: BBAR) traded around $18.44, up roughly $1.48 on the session (about +8.7% versus the prior close), with trading ranging from roughly $16.57 to $18.50. That kind of single-day swing is not unusual for Argentine financial stocks, which often behave like a “macro instrument” first and a bank second. But today’s move is landing on top of a stack of genuinely fresh, stock-specific developments: a
18 December 2025
·
Heartflow (HTFL) Stock Surges on Insider Buying as Analysts See Upside: News, Forecasts, and Key Risks for December 18, 2025

Heartflow (HTFL) Stock Surges on Insider Buying as Analysts See Upside: News, Forecasts, and Key Risks for December 18, 2025

Heartflow, Inc. (NASDAQ: HTFL) is in the spotlight on December 18, 2025, after shares jumped sharply following a newly disclosed insider purchase—the kind of headline that can kick a newly public medtech name into high gear for a day (and sometimes longer). MarketBeat+2Investing.com+2 Below is a full, publication-ready breakdown of today’s news, the latest analyst forecasts, and the most important fundamentals shaping the Heartflow stock story right now. What happened to Heartflow stock on December 18, 2025? Heartflow stock rallied after news broke that Director Jeffrey C. Lightcap bought 40,000 shares in the open market. MarketBeat reported the stock was
18 December 2025
·
India’s SHANTI Bill Passes Parliament: Private Entry into Nuclear Power, Liability Overhaul, and Protests Explained

India’s SHANTI Bill Passes Parliament: Private Entry into Nuclear Power, Liability Overhaul, and Protests Explained

New Delhi witnessed a watershed moment in India’s clean-energy debate on December 18, 2025, as Parliament cleared the Sustainable Harnessing and Advancement of Nuclear Energy for Transforming India (SHANTI) Bill, 2025—legislation the government says will unlock investment and accelerate nuclear expansion, and critics say weakens accountability in one of the country’s most sensitive sectors. www.ndtv.com+2Reuters+2 The bill’s passage immediately triggered a political and social backlash: opposition parties raised alarms in the Rajya Sabha over safety, regulation, and liability, while power engineers, central trade unions and farmers’ groups announced nationwide protests from December 23, demanding the bill’s withdrawal. The Economic Times+2ETEnergyworld.com+2
18 December 2025
1 … 373 374 375 376 377 … 535

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Go toTop